National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

pegaspargase (peg-A-spar-jayz)

 A drug used to treat acute lymphoblastic leukemia (ALL). It is a form of the drug asparaginase that is linked to a substance called PEG, which makes the drug stay in the body longer. Asparaginase is an enzyme that breaks down the amino acid asparagine and may block the growth of tumor cells that need asparagine to grow. It is a type of protein synthesis inhibitor. Also called Oncaspar and PEG-asparaginase.



Previous Definitions:PEG-interferon alfa-2a, PEG-interferon alfa-2b, PEG-Intron, PEG-MGDF, PEG-rhMGDF
Next Definitions:Pegasys, pegfilgrastim, pegylated arginine deiminase, PEITC, pelargonium

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov